Literature DB >> 18190242

Chromosomal gains and losses indicate oncogene and tumor suppressor gene candidates in salivary gland tumors.

M Giefing1, M Wierzbicka, M Rydzanicz, R Cegla, M Kujawski, K Szyfter.   

Abstract

The incidence of salivary gland tumor in Poland is growing in the last two decades. Simultaneously a progress in understanding the genetic mechanisms of formation of this tumor was achieved by detecting several genes like PLAG1 involved in its pathogenesis. In this study we perform a whole genome, CGH analysis with the aim to identify recurrent, chromosomal copy number changes possibly indicating novel tumor suppressor gene or oncogene loci. 29 salivary tumor samples: Cystadenolymphoma-warthin (15) and adenoma polymorphum (14) located in the parotid (27) and submandibular gland (2) were collected and CGH was performed. The established copy number profiles were compared in order to asses the smallest common region of gains and losses. The delineated regions were further analyzed with the UCSC Genome Browser on Human Mar. 2006 Assembly to asses their gene content. Altogether, salivary gland tumors presented a different aberration pattern than these reported for head and neck squamous cell carcinoma (HNSCC) but no significant differences were observed between Warthin and adenoma polymorphum tumors. Moreover, several potential tumor suppressor genes and oncogenes were identified in the smallest, common altered regions. We show a frequent deletion of the harakiri gene (12q24.2) in 12/29 tumors and TP53 gene (17p13.1) in 11/29 tumors as potential tumor suppressors in salivary gland cancers. Besides, we detected a frequent amplification of the 13q22.1-22.2 region in 13/29 cases harboring the KLF5 and KLF12 genes. KLF5 regulates the expression of survivin, an oncogene widely expressed in the majority of human cancers. The observed alterations may indicate important genetic events in the formation of salivary gland tumors. Especially the amplification in 13q may be a mechanism contributing to the expression of survivin and tumor progression.

Entities:  

Mesh:

Year:  2008        PMID: 18190242

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  17 in total

1.  NFKB1 -94 insertion/deletion polymorphism and cancer risk: a meta-analysis.

Authors:  Linlin Xu; Shaoyi Huang; Wei Chen; Zhichun Song; Shu Cai
Journal:  Tumour Biol       Date:  2014-02-16

Review 2.  Mammalian Krüppel-like factors in health and diseases.

Authors:  Beth B McConnell; Vincent W Yang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

Review 3.  Krüppel-like factors in hepatocellular carcinoma.

Authors:  Xiao-Jie Lu; Yan Shi; Jin-Lian Chen; Shijie Ma
Journal:  Tumour Biol       Date:  2015-02-06

Review 4.  Role of Krüppel-like factors in cancer stem cells.

Authors:  Yueling Zhang; Jin Hao; Yingcheng Zheng; Dian Jing; Yu Shen; Jun Wang; Zhihe Zhao
Journal:  J Physiol Biochem       Date:  2015-01-24       Impact factor: 4.158

Review 5.  Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases.

Authors:  Jin-Tang Dong; Ceshi Chen
Journal:  Cell Mol Life Sci       Date:  2009-05-16       Impact factor: 9.261

6.  Krüppel-like factors 4 and 5: unity in diversity.

Authors:  Inderpreet Sur
Journal:  Curr Genomics       Date:  2009-12       Impact factor: 2.236

7.  miR-137 plays tumor suppressor roles in gastric cancer cell lines by targeting KLF12 and MYO1C.

Authors:  Yantao Du; Yichen Chen; Furong Wang; Liankun Gu
Journal:  Tumour Biol       Date:  2016-07-28

Review 8.  The role of Krüppel-like factors in the reprogramming of somatic cells to induced pluripotent stem cells.

Authors:  Mandayam O Nandan; Vincent W Yang
Journal:  Histol Histopathol       Date:  2009-10       Impact factor: 2.303

Review 9.  Unraveling cancer lineage drivers in squamous cell carcinomas.

Authors:  Yinglu Guan; Guan Wang; Danielle Fails; Priyadharsini Nagarajan; Yejing Ge
Journal:  Pharmacol Ther       Date:  2019-12-11       Impact factor: 12.310

10.  Somatic Superenhancer Duplications and Hotspot Mutations Lead to Oncogenic Activation of the KLF5 Transcription Factor.

Authors:  Xiaoyang Zhang; Peter S Choi; Joshua M Francis; Galen F Gao; Joshua D Campbell; Aruna Ramachandran; Yoichiro Mitsuishi; Gavin Ha; Juliann Shih; Francisca Vazquez; Aviad Tsherniak; Alison M Taylor; Jin Zhou; Zhong Wu; Ashton C Berger; Marios Giannakis; William C Hahn; Andrew D Cherniack; Matthew Meyerson
Journal:  Cancer Discov       Date:  2017-09-29       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.